Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital: A Prospective Observational Study. (EVAQSAP-HDJ-BC)

24. april 2026 oppdatert av: Centre Hospitalier de Martigues

Evaluation and Analysis of Patient Satisfaction Following Multidisciplinary Complex Assessment in Day Hospital: Determinants and Implications for Continuous Quality Improvement

This study aims to evaluate patient satisfaction following a multidisciplinary "complex assessment" conducted in a Day Hospital setting at the Centre Hospitalier de Martigues. This assessment is part of routine care for patients diagnosed with cancer and scheduled to receive injectable anticancer treatment.

During this assessment, patients meet several healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The objective is to identify patient-specific needs and improve coordination of care at an early stage of the treatment pathway.

This is a prospective observational study based on an anonymous satisfaction questionnaire distributed to eligible adult patients after completion of the Day Hospital assessment. The primary objective is to assess overall patient satisfaction. Secondary objectives include evaluating satisfaction by specialty, identifying factors associated with satisfaction, and assessing the Net Promoter Score (NPS).

The results of this study are expected to help identify strengths and areas for improvement in multidisciplinary care, enhance patient-centered care, and support continuous quality improvement in oncology practice.

Studieoversikt

Detaljert beskrivelse

Cancer care requires a multidisciplinary and patient-centered approach to address the complex medical, psychological, and social needs of patients. In this context, a "complex assessment" program has been implemented in the Day Hospital (HDJ) of the Centre Hospitalier de Martigues for patients with various types of cancer (breast, gynecological, urological, digestive, hematological, and pulmonary) prior to initiation of injectable anticancer therapies.

This program involves coordinated consultations with multiple healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The aim is to identify vulnerabilities, optimize supportive care, and improve the overall patient care pathway.

This study is designed as a prospective observational study evaluating patient satisfaction with this multidisciplinary intervention. All eligible adult patients who undergo the Day Hospital complex assessment are invited to complete an anonymous satisfaction questionnaire. The questionnaire includes items related to the quality of care, interactions with healthcare professionals, organization of care, and overall satisfaction, as well as a Net Promoter Score (NPS).

The primary endpoint is the proportion of patients reporting high overall satisfaction. Secondary endpoints include satisfaction levels by healthcare professional category, identification of determinants associated with satisfaction, and evaluation of the NPS according to demographic and clinical characteristics.

Statistical analyses will include descriptive statistics, univariate and multivariate analyses to identify factors associated with patient satisfaction. Results from this study will provide valuable insights into patient experience and contribute to the continuous improvement of multidisciplinary oncology care in a non-university hospital setting.

Studietype

Observasjonsmessig

Registrering (Antatt)

309

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

  • Navn: MARTIN Gwenola healthcare manager of the day hospital, Diploma in Health Care Managem
  • Telefonnummer: +33-04 42 43 27 56
  • E-post: Gwenola.MARTIN@ch-martigues.fr

Studiesteder

    • Bouches du Rhone
      • Martigues, Bouches du Rhone, Frankrike, 13500
        • Rekruttering
        • Centre Hospitalier de Martigues
        • Ta kontakt med:
        • Ta kontakt med:
          • MARTIN Gwenola healthcare manager of the day hospital, Diploma in Health Care Managem
          • Telefonnummer: +33 +33-04 42 43 27 56
          • E-post: Gwenola.MARTIN@ch-martigues.fr
        • Hovedetterforsker:
          • GERARDIN Eric, doctor
        • Underetterforsker:
          • CHEVALIER Thomas, doctor

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Adult patients with cancer treated at the Centre Hospitalier de Martigues and undergoing a multidisciplinary complex assessment in a Day Hospital setting prior to initiation of injectable anticancer therapy.

Beskrivelse

Inclusion Criteria:

  • Adult patients (≥ 18 years old)
  • Patients undergoing a multidisciplinary "complex assessment" in a Day Hospital setting
  • Patients diagnosed with cancer and scheduled to receive injectable anticancer treatment
  • Ability to understand and complete the satisfaction questionnaire
  • Patients who have been informed and have not opposed participation

Exclusion Criteria:

  • Patients under 18 years of age
  • Patients unable to complete the questionnaire (e.g., severe cognitive impairment or major language barrier)
  • Patients who refuse participation
  • Patients with incomplete Day Hospital complex assessment
  • Patients under legal protection (guardianship or curatorship)

Patients under legal protection (guardianship or curatorship)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Patients undergoing multidisciplinary complex assessment in Day Hospital
Adult patients with cancer undergoing a multidisciplinary "complex assessment" in a Day Hospital setting prior to initiation of injectable anticancer treatment, including consultations with healthcare professionals and completion of a satisfaction questionnaire.
Routine multidisciplinary assessment conducted in a Day Hospital setting involving consultations with healthcare professionals (pharmacist, dietitian, psychologist, social worker, and supportive care providers) as part of standard oncology care.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall Patient Satisfaction
Tidsramme: At completion of the Day Hospital assessment (within 1 month after assessment)
Proportion of patients reporting high overall satisfaction following the multidisciplinary complex assessment, measured using an anonymous satisfaction questionnaire.
At completion of the Day Hospital assessment (within 1 month after assessment)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

10. juli 2025

Primær fullføring (Antatt)

15. mars 2029

Studiet fullført (Antatt)

15. april 2029

Datoer for studieregistrering

Først innsendt

24. april 2026

Først innsendt som oppfylte QC-kriteriene

24. april 2026

Først lagt ut (Faktiske)

1. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

24. april 2026

Sist bekreftet

1. april 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2024-A02062-45-EVAQSAP-HDJ-BC
  • 2024-A02062-45 (Annen identifikator: ANSM)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared due to the observational nature of the study and institutional and regulatory constraints related to data protection and confidentiality. Only aggregated results will be reported in scientific publications.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere